title: Non-specific activity of (+/-)CP-96,345 in models of pain and inflammation.
authors.affiliation: Department of Medicinal Biology, Pfizer Inc., Aichi, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Nagahisa
authors.forename: R
authors.initials: R
authors.lastname: Asai
authors.forename: Y
authors.initials: Y
authors.lastname: Kanai
authors.forename: A
authors.initials: A
authors.lastname: Murase
authors.forename: M
authors.initials: M
authors.lastname: Tsuchiya-Nakagaki
authors.forename: T
authors.initials: T
authors.lastname: Nakagaki
authors.forename: T C
authors.initials: TC
authors.lastname: Shieh
authors.forename: K
authors.initials: K
authors.lastname: Taniguchi
mesh_terms: D000818:Animals; D001713:Biphenyl Compounds / Q000494:pharmacology*; D002351:Carrageenan; D004305:Dose-Response Relationship, Drug; D004487:Edema; D006930:Hyperalgesia / Q000188:drug therapy; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology*; D064729:Neurokinin-1 Receptor Antagonists; D010146:Pain / Q000188:drug therapy / Q000503:physiopathology*; D051381:Rats; D013237:Stereoisomerism; D013373:Substance P / Q000037:antagonists & inhibitors; D013997:Time Factors; D014700:Verapamil / Q000494:pharmacology
chemical_list: D001713:Biphenyl Compounds; D006993:Hypnotics and Sedatives; D064729:Neurokinin-1 Receptor Antagonists; D013373:Substance P; D002351:Carrageenan; D014700:Verapamil; C066892:CP 96345